Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $8,625 | 9 | 47.9% |
| Food and Beverage | $5,915 | 258 | 32.8% |
| Consulting Fee | $3,450 | 3 | 19.2% |
| Education | $18.51 | 2 | 0.1% |
| Travel and Lodging | $4.44 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $11,853 | 22 | $0 (2022) |
| Ascensia Diabetes Care Us Inc. | $801.23 | 4 | $0 (2022) |
| Dexcom, Inc. | $627.92 | 14 | $0 (2022) |
| Novo Nordisk Inc | $607.39 | 38 | $0 (2022) |
| Lilly USA, LLC | $535.62 | 23 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $470.36 | 24 | $0 (2022) |
| Insulet Corporation | $468.05 | 30 | $0 (2022) |
| Bayer HealthCare Pharmaceuticals Inc. | $420.06 | 16 | $0 (2022) |
| Amgen Inc. | $298.63 | 13 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $273.02 | 7 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $170.39 | 3 | MannKind Corporation ($100.49) |
| 2022 | $7,331 | 143 | Medtronic, Inc. ($4,009) |
| 2021 | $10,511 | 127 | Medtronic, Inc. ($7,844) |
All Payment Transactions
273 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/16/2023 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $53.77 | General |
| Category: Automated insulin delivery system | ||||||
| 06/16/2023 | MannKind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $100.49 | General |
| Category: DIABETES MEDICINE | ||||||
| 01/27/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: Diabetes Care | ||||||
| 12/20/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: DIABETES | ||||||
| 12/19/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $11.39 | General |
| Category: Obesity | ||||||
| 12/16/2022 | Lilly USA, LLC | BAQSIMI (Drug), LYUMJEV | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: Diabetes | ||||||
| 12/13/2022 | Antares Pharma, Inc. | NOCDURNA (Drug), XYOSTED, TLANDO | Food and Beverage | In-kind items and services | $2.36 | General |
| Category: NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | ||||||
| 12/09/2022 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $118.23 | General |
| Category: Insulin Pump | ||||||
| 12/08/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Cardio-renal | ||||||
| 12/05/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: Diabetes | ||||||
| 11/30/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.05 | General |
| Category: Diabetes | ||||||
| 11/30/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Obesity | ||||||
| 11/30/2022 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: Diabetes Care | ||||||
| 11/30/2022 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Diabetes Care | ||||||
| 11/28/2022 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/22/2022 | RECORDATI_RARE_DISEASES_INC. | SIGNIFOR LAR (Drug), ISTURISA | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: ENDOCRINE AGENT | ||||||
| 11/22/2022 | EUSA Pharma (US) LLC | Sylvant (Drug) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: Hematology | ||||||
| 11/21/2022 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: Endocrinology | ||||||
| 11/20/2022 | Antares Pharma, Inc. | NOCDURNA (Drug), XYOSTED, TLANDO | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | ||||||
| 11/16/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: Diabetes | ||||||
| 11/16/2022 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $18.27 | General |
| Category: Insulin Pump | ||||||
| 11/14/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: DIABETES | ||||||
| 11/12/2022 | Lilly USA, LLC | BAQSIMI (Drug), LYUMJEV | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Diabetes | ||||||
| 11/09/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Cardio-renal | ||||||
| 11/08/2022 | Antares Pharma, Inc. | NOCDURNA (Drug), XYOSTED, TLANDO | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 6 | 398 | 817 | $72,599 | $24,643 |
| 2021 | 6 | 436 | 793 | $67,185 | $23,874 |
| 2020 | 9 | 384 | 590 | $64,583 | $21,764 |
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 104 | 225 | $47,976 | $16,629 | 34.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 17 | 26 | $7,710 | $2,920 | 37.9% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 46 | 111 | $9,657 | $2,378 | 24.6% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 92 | 202 | $5,252 | $1,918 | 36.5% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 91 | 199 | $1,194 | $637.96 | 53.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 48 | 54 | $810.00 | $159.51 | 19.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 109 | 210 | $44,100 | $16,419 | 37.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 19 | 24 | $6,792 | $2,503 | 36.9% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 45 | 106 | $9,222 | $2,401 | 26.0% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 96 | 174 | $4,524 | $1,670 | 36.9% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2021 | 97 | 182 | $1,092 | $590.40 | 54.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 70 | 97 | $1,455 | $291.00 | 20.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 98 | 180 | $37,800 | $12,190 | 32.2% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 31 | 38 | $6,353 | $2,683 | 42.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 35 | 41 | $4,962 | $1,862 | 37.5% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2020 | 31 | 67 | $5,829 | $1,601 | 27.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 13 | 15 | $4,245 | $1,487 | 35.0% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 79 | 113 | $2,938 | $1,095 | 37.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 11 | 11 | $1,562 | $441.79 | 28.3% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2020 | 75 | 109 | $654.00 | $356.40 | 54.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 11 | 16 | $240.00 | $47.82 | 19.9% |
About Elizabeth Nardacci, NP
Elizabeth Nardacci, NP is a Nurse Practitioner healthcare provider based in Albany, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1356330351.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Elizabeth Nardacci, NP has received a total of $18,013 in payments from pharmaceutical and medical device companies, with $170.39 received in 2023. These payments were reported across 273 transactions from 33 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($8,625).
As a Medicare-enrolled provider, Nardacci has provided services to 1,218 Medicare beneficiaries, totaling 2,200 services with total Medicare billing of $70,281. Data is available for 3 years (2020–2022), covering 21 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Location Albany, NY
- Active Since 10/21/2005
- Last Updated 05/19/2021
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1356330351
Products in Payments
- Minimed 770G System (Device) $2,160
- Minimed 630G (Device) $2,125
- MINIMED 770G (Device) $1,500
- INPEN SMART INSULIN DELIVERY SYSTEM (Device) $1,340
- MINIMED 630G (Device) $1,169
- iPro2 (Device) $1,000
- JARDIANCE (Drug) $512.78
- Omnipod (Device) $468.05
- Dexcom G6 Transmitter (Medical Supply) $458.05
- Kerendia (Drug) $420.06
- FARXIGA (Drug) $273.02
- InPen (Device) $250.00
- EVENITY (Biological) $205.67
- Ozempic (Drug) $194.36
- Saxenda (Drug) $186.66
- DEXCOM G6 TRANSMITTER (Device) $169.87
- Rybelsus (Drug) $152.95
- TEPEZZA (Drug) $148.82
- MOUNJARO (Drug) $143.88
- NOCDURNA (Drug) $136.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Albany
Elizabeth Tye, Fnp-C, FNP-C
Nurse Practitioner — Payments: $67,530
Valerie Stanley, Np, NP
Nurse Practitioner — Payments: $53,966
Ms. Marie Schongar, Rn,Ms,Fnp-C, Cde, RN,MS,FNP-C, CDE
Nurse Practitioner — Payments: $22,854
Stephen Jones, Np, NP
Nurse Practitioner — Payments: $17,070
Mary Hockman, Np-C, NP-C
Nurse Practitioner — Payments: $7,638
Ian Sherman, Agpcnp-Bc, AGPCNP-BC
Nurse Practitioner — Payments: $7,497